Clarify Pharma PLC Notice of Annual General Meeting (5956C)
13 Juni 2023 - 4:51PM
UK Regulatory
TIDMPSYC
RNS Number : 5956C
Clarify Pharma PLC
13 June 2023
13 June 2023
Clarify Pharma PLC
("Clarify Pharma" or "the Company")
Notice of Annual General Meeting
Clarify Pharma (AQSE: PSYC), an investment vehicle specialising
in biotech and life sciences companies seeking to prove the safety
and efficacy of psychedelic-based substances, announces that it
will hold its Annual General Meeting ('AGM') on Wednesday 5 July
2023 at 11 am BST, at the offices of Lomas & Co, Bridge House,
12 Market Street, Glossop, Derbyshire SK13 8AR.
Further details on the arrangement for this year's AGM are set
out in the Notice of AGM, which together with the Form of Proxy,
have been posted to shareholders today. The Notice of AGM will
shortly also be available on the Company's website.
For further information, please visit www.clarifypharma.com or
contact:
Clarify Pharma
Jon Bixby via First Sentinel
Executive Chairman
-------------------------
First Sentinel
-------------------------
Corporate Adviser
Brian Stockbridge +44 7876 888 011
-------------------------
About Clarify Pharma PLC:
Listed on the Aquis Stock Exchange in London, Clarify Pharma is
an investment vehicle focusing on investing in biotech and life
sciences companies seeking to prove the safety and efficacy of
psychedelic based substances. The Company looks to identify
investment opportunities in the life sciences sector within the UK,
Canada and other growing markets, with the objective of generating
long-term capital growth and building investments in an R&D
pipeline of companies which are discovering, developing, or
deploying safe and evidence-based psychedelic inspired medicines
and experiential therapies that alleviate mental health problems
and enhance wellbeing. The Company's Directors have an established
track record, experience and networks in the psychedelic,
cannabinoid and media industries, to drive value creation.
www.clarifypharma.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXUOSSROKUNAAR
(END) Dow Jones Newswires
June 13, 2023 10:51 ET (14:51 GMT)
Clarify Pharma (AQSE:PSYC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Clarify Pharma (AQSE:PSYC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024